At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The ORANGE II PLUS - Trial: an International Multicenter Randomized Controlled Trial of Open Versus Laparoscopic Hemihepatectomies.
In Brief
A clinical study evaluating Open or Laparoscopic left hemihepatectomy and Open or Laparoscopic right hemihepatectomy for Liver Lesions Requiring Hemihepatectomy. Completed, enrolled 350 participants across 16 sites in 6 countries.
Detailed Summary
The added value of the laparoscopic hemihepatectomy compared to the open hemihepatectomy has never been studied in a randomized controlled setting. Therefore, the multicenter international ORANGE II PLUS - trial has been constructed and will provide evidence on the merits of laparoscopic versus open hemihepatectomy in terms of time to functional recovery, hospital length of stay, intraoperative blood loss, operation time, resection margin, time to adjuvant chemotherapy initiation, readmission percentage, (liver-specific) morbidity, quality of life, body image, reasons for delay of discharge after functional recovery, long term incidence of incisional hernias, hospital and societal costs during one year and overall five-year survival.
Study Details
Timeline
Interventions
Patients in this arm will undergo a left hemihepatectomy within an Enhanced Recovery After Surgery Program.
Patients in this arm will undergo a right hemihepatectomy within an Enhanced Recovery After Surgery Program.